Literature DB >> 6414690

Ifosfamide, mesna and vincristine in paediatric oncology.

J de Kraker, P A Voûte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6414690     DOI： 10.1016/s0305-7372(83)80024-3

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  9 in total

Review 1.  Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer.

Authors:  K L Dechant; R N Brogden; T Pilkington; D Faulds
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

2.  High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma.

Authors:  H Jürgens; U Exner; J Kühl; J Ritter; J Treuner; P Weinel; K Winkler; U Göbel
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Alkylating activity in serum, urine, and CSF following high-dose ifosfamide in children.

Authors:  J Ninane; R Baurain; J de Kraker; A Ferster; A Trouet; G Cornu
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  How curable is relapsed Wilms' tumour? The United Kingdom Children's Cancer Study Group.

Authors:  J J Groot-Loonen; C R Pinkerton; P H Morris-Jones; J Pritchard
Journal:  Arch Dis Child       Date:  1990-09       Impact factor: 3.791

5.  Severe encephalopathy associated with ifosfamide administration in two children with metastatic tumors.

Authors:  M A Gieron; L S Barak; J Estrada
Journal:  J Neurooncol       Date:  1988       Impact factor: 4.130

6.  A phase II study of ifosfamide in the treatment of relapses in Wilms' tumor.

Authors:  M F Tournade
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

7.  Experience with ifosfamide in paediatric tumours.

Authors:  J de Kraker; P A Voûte
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

8.  Bone metabolism and mineralisation after cytotoxic chemotherapy including ifosfamide.

Authors:  J de Schepper; S Hachimi-Idrissi; O Louis; R Maurus; J Otten
Journal:  Arch Dis Child       Date:  1994-10       Impact factor: 3.791

9.  Circulating Natural IgM Antibodies Against Angiogenin in the Peripheral Blood Sera of Patients with Osteosarcoma as Candidate Biomarkers and Reporters of Tumorigenesis.

Authors:  Yulia A Savitskaya; Genaro Rico; Luis Linares; Roberto González; René Téllez; Eréndira Estrada; Norma Marín; Elisa Martínez; Alfonso Alfaro; Clemente Ibarra
Journal:  Biomark Cancer       Date:  2010-11-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.